Transcriptional Regulation of Type I Diabetes by NF-κB

Journal of Immunology

Volumn 171, Issue 9, 2003, Pages 4886-4892

  Lamhamedi Cherradi, Salah Eddine ^a,c   Zheng, Shijun ^a   Hilliard, Brendan A ^a   Xu, Lingyun ^a   Sun, Jing ^a   Alsheadat, Saaib ^a   Liou, Hsiou Chi ^b   Chen, Youhai H ^a,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c Tanox Biosystems Inc   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BONE MARROW CELL; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSCRIPTION; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOZOCIN DIABETES; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

EID: 0142241399     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.9.4886     Document Type: Article

References (39)

1. Wicker, L. S., J. A. Todd, and L. B. Peterson. 1995. Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13:179.
2. Crisa, L., J. P. Mordes, and A. A. Rossini. 1992. Autoimmune diabetes mellitus in the BB rat. Diabetes Metab. Rev. 8:4.
3. Rabinovitch, A., and J. S. Skyler. 1998. Prevention of type I diabetes. Med. Clin. N. Am. 82:739.
4. Gilmore, T. D., M. Koedood, K. A. Piffat, and D. W. White. 1996. Rel/NF-κB/ IκB proteins and cancer. Oncogene 13:1367.
5. Stancovski, I., and D. Baltimore. 1997. NF-κB activation: the IκB kinase revealed? Cell 91:299.
6. DiDonato, J., F. Mercurio, C. Rosette, J. Wu-Li, H. Suyang, S. Ghosh, and M. Karin. 1996. Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell Biol. 16:1295.
7. Chen, Z. J., L. Parent, and T. Maniatis. 1996. Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity. Cell 84:853.
8. Barnes, P. J., and M. Karin. 1997. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336:1066.
9. Liou, H. C., Z. Jin, J. Tumang, S. Andjelic, K. A. Smith, and M. L. Liou. 1999. c-Rel is crucial for lymphocyte proliferation but dispensable for T cell effector function. Int. Immunol. 11:361.
10. Tumang, J. R., A. Owyang, S. Andjelic, Z. Jin, R. R. Hardy, M. L. Liou, and H. C. Liou. 1998. c-Rel is essential for B lymphocyte survival and cell cycle progression. Eur. J. Immunol. 28:4299.
11. Gerondakis, S., A. Strasser, D. Metcalf, G. Grigoriadis, J. Y. Scheerlinck, and R. J. Grumont. 1996. Rel-deficient T cells exhibit defects in production of interleukin-3 and granulocyte-macrophage colony-stimulating factor. Proc. Natl. Acad. Sci. USA 93:3405.
12. Grumont, R. J., I. J. Rourke, and S. Gerondakis. 1999. Rel-dependent induction of A1 transcription is required to protect B cells from Ag receptor ligation-induced apoptosis. Genes Dev. 13:400.
13. Sha, W. C., H. C. Liou, E. I. Tuomanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80:321.
14. Beg, A. A., W. C. Sha, R. T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376:167.
15. Doi, T. S., T. Takahashi, O. Taguchi, T. Azuma, and Y. Obata. 1997. NF-κB RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses. J. Exp. Med. 185:953.
16. Weih, F., D. Carrasco, S. K. Durham, D. S. Barton, C. A. Rizzo, R. P. Ryseck, S. A. Lira, and R. Bravo. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κ B/Rel family. Cell 80:331.
17. Caamano, J. H., C. A. Rizzo, S. K. Durham, D. S. Barton, C. Raventos-Suarez, C. M. Snapper, and R. Bravo. 1998. NF-κB2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J. Exp. Med. 187:185.
18. Franzoso, G., L. Carlson, L. Poljak, E. W. Shores, S. Epstein, A. Leonardi, A. Grinberg, T. Tran, T. Scharton-Kersten, M. Anver, et al. 1998. Mice deficient in nuclear factor (NF)-κB/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J. Exp. Med. 187:147.
19. Like, A. A., and A. A. Rossini. 1976. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193:415.
20. Kolb, H. 1987. Mouse models of insulin dependent diabetes: low-dose streptozocin-induced diabetes and nonobese diabetic (NOD) mice. Diabetes Metab. Rev. 3:751.
21. Kolb-Bachofen, V., S. Epstein, U. Kiesel, and H. Kolb. 1988. Low-dose streptozocin-induced diabetes in mice: electron microscopy reveals single-cell insulitis before diabetes onset. Diabetes 37:21.
22. Tsuji, A., and H. Sakurai. 1998. Generation of nitric oxide from streptozotocin (STZ) in the presence of copper(II) plus ascorbate: implication for the development of STZ-induced diabetes. Biochem. Biophys. Res. Commun. 245:11.
23. Kwon, N. S., S. H. Lee, C. S. Choi, T. Kho, and H. S. Lee. 1994. Nitric oxide generation from streptozotocin. FASEB J. 8:529.
24. Lukic, M. L., S. Stosic-Grujicic, and A. Shahin. 1998. Effector mechanisms in low-dose streptozotocin-induced diabetes. Dev. Immunol. 6:119.
25. Kim, Y. T., and C. Steinberg. 1984. Immunologic studies on the induction of diabetes in experimental animals: cellular basis for the induction of diabetes by streptozotocin. Diabetes 33:771.
26. Herold, K. C., J. A. Bluestone, A. G. Montag, A. Parihar, A. Wiegner, R. E. Gress, and R. Hirsch. 1992. Prevention of autoimmune diabetes with non-activating anti-CD3 monoclonal antibody. Diabetes 41:385.
27. Herold, K. C., A. G. Montag, and F. Buckingham. 1992. Induction of tolerance to autoimmune diabetes with islet Ags. J. Exp. Med. 176:1107.
28. Herold, K. C., A. G. Montag, and F. W. Fitch. 1987. Treatment with anti-T-lymphocyte antibodies prevents induction of insulitis in mice given multiple doses of streptozocin. Diabetes 36:796.
29. Buschard, K., and J. Rygaard. 1977. Passive transfer of streptozotocin induced diabetes mellitus with spleen cells: studies of synogeneic and allogeneic transfer to normal and athymic nude mice. Acta. Pathol. Microbiol. Scand. Suppl. 85C:469.
30. Hilliard, B., N. Mason, L. Xu, J. Sun, S.-E. Lamhamedi-Cherradi, H.-C. Liou, C. Hunter, and Y. Chen. 2002. Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation. J. Clin. Invest. 110:843.
31. Hilliard, B., E. B. Samoilova, T. T. Liu, A. M. Rostami, and Y. Chen. 1999. Experimental autoimmune encephalomyelitis in Nuclear factor-κ B-deficient mice: roles of Nuclear factor-κB in the activation and differentiation of autoreactive T cells. J. Immunol. 163:2937.
32. Cardozo, A. K., H. Heimberg, Y. Heremans, R. Leeman, B. Kutlu, M. Kruhoffer, T. Orntoft, and D. L. Eizirik. 2001. A comprehensive analysis of cytokine-induced and Nuclear factor-κB-dependent genes in primary rat pancreatic β-cells. J. Biol. Chem. 276:48879.
33. Mabley, J. G., G. Hasko, L. Liaudet, F. Soriano, G. J. Southan, A. L. Salzman, and C. Szabo. 2002. NF-κB1 (p50)-deficient mice are not susceptible to multiple low-dose streptozotocin-induced diabetes. J. Endocrinol. 173:457.
34. Ouaaz, F., J. Arron, Y. Zheng, Y. Choi, and A. A. Beg. 2002. Dendritic cell development and survival require distinct NF-κB subunits. Immunity 16:257.
35. + dendritic cells by specifically inducing p35 gene transcription. J. Exp. Med. 194:1021.
36. Sanjabi, S., A. Hoffmann, H. C. Liou, D. Baltimore, and S. T. Smale. 2000. Selective requirement for c-Rel during IL-12 P40 gene induction in macrophages. Proc. Natl. Acad. Sci. USA 97:12705.
37. Weinmann, A. S., D. M. Mitchell, S. Sanjabi, M. N. Bradley, A. Hoffmann, H. C. Liou, and S. T. Smale. 2001. Nucleosome remodeling at the IL-12 p40 promoter is a TLR-dependent, Rel-independent event. Nat. Immun. 2:51.
38. Ho, E., G. Chen, and T. M. Bray. 2000. Alpha-phenyl-tert-butylnitrone (PBN) inhibits NF-κB activation offering protection against chemically induced diabetes. Free Radical Biol. Med. 28:604.
39. Doyle, A. G., and I. P. Fraser. 1996. Murine macrophages: isolation, cultivation, and characterization. In Weir's Handbook of Experimental Immunology Vol. IV. L. A. Herzenberg, D. M. Weir, and C. Blackwell, eds. Blackwell, Malden, p. 154.1.